Price differences are especially pertinent with these weight loss drugs, which are officially called glucagon-like peptide-1 ...

People with type 1 diabetes who need to lose weight can benefit from the blockbuster GLP-1 drug semaglutide currently ...

Under the deal, cash-paying patients can access a month's supply of Wegovy through the Danish drugmaker's Novocare pharmacy ...

Novo Nordisk announces collaboration with WeightWatchers to offer patients living with obesity access to FDA-approved Wegovy ...

India's anti-obesity drug market is currently valued at Rs 3,000-3,500 crore & is projected to grow nearly eightfold by 2030, according to market estimates.

Compounded weight loss drugs have been mostly off the market for about a month, but the weight loss drug industry remains as unsettled as ever.

Hims & Hers lost a valuable collaboration with Novo Nordisk over compounded GLP-1s. Could it hurt the company's potential to ...

MUMBAI -- Danish pharmaceutical major Novo Nordisk on Tuesday launched its Wegovy weight loss drug in India, debuting the medicine ahead of schedule and just months after American rival Eli Lilly ...

WEIGHT loss jabs may also help ward off dementia, a new study suggests. Researchers found that semaglutide – the active ...

Danish company Novo Nordisk is set to launch Wegovy for weight loss, in India on Tuesday. The injectable product, called the ...

An experimental muscle-preserving drug called bimagrumab helped people taking semaglutide (Ozempic/Wegovy) keep their muscle ...

Danish company Novo Nordisk is set to launch Wegovy for weight loss, in India on Tuesday. The injectable product, called the ...